The effect of twelve weeks of treatment with ezetimibe on HDV RNA level in patients with chronic hepatitis D

BACKGROUND/AIMS: Sodium taurocholate co-transporting polypeptide (NTCP) is the receptor for the hepatitis B virus (HBV) and hepatitis D virus (HDV) entry into hepatocytes. Ezetimibe is a cholesterol-lowering drug that possesses the pharmacophore features to inhibit NTCP. This study evaluates the eff...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Turk J Gastroenterol
Autors principals: Abbas, Zaigham, Saad, Muhammad, Asim, Muhammad, Abbas, Minaam, Samejo, Shoukat Ali
Format: Artigo
Idioma:Inglês
Publicat: Turkish Society of Gastroenterology 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7062136/
https://ncbi.nlm.nih.gov/pubmed/32141822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/tjg.2020.18846
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars